交易 Capricor Therapeutics Inc - CAPR CFD

Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases. The company''s lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase II clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with COVID-19; and completed various trials investigating the use of CAP-1002 for the treatment of cardiac conditions, including heart failure and post myocardial infarction with cardiac dysfunction. It is also developing CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in preclinical stage for the potential prevention of COVID-19. Capricor collaborates with Lonza Houston, Inc. for the development of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in Beverly Hills, California.

最新股票文章

关税生效背景下如何交易纳斯达克100指数
关税生效背景下如何交易纳斯达克100指数
科技股大涨助力市场反弹,纳指期货走高;投资者密切关注关税影响及美联储政策走向
21 小时前
中国的经济危机比想象中还严重?
中国的经济危机比想象中还严重?
中国经济正面临严重困境,而这张图说明了原因。图中显示的是中国的房地产投资、新开工项目和房屋销售情况。可以看到,这三项指标在2021年年中达到峰值后大幅下滑。
15:45, 27 七月 2025
特斯拉财报“爆雷”后如何交易?
特斯拉财报“爆雷”后如何交易?
第二季度财报不及预期,股价盘后下跌,马斯克警告“接下来几个季度可能会较为艰难”
20:21, 24 七月 2025
迈克尔·伯里的投资组合
迈克尔·伯里为何清仓所有股票
迈克尔·伯里(Michael Burry)刚刚抛售了价值超过7000万美元的股票,清仓了整个投资组合,仅保留了一只股票,并加码投资一家其他投资者纷纷撤出的公司。伯里是极少数在2008年金融危机前成功预见市场崩溃的投资者之一,他做空房地产市场,一举赚取了7亿美元。
18:01, 22 七月 2025